MeSH tree: D20.215.894.865.450
UVA Health scientists have developed a promising new way to create vaccines that could be faster, cheaper, and easier to distribute than current options. The University of Virginia School of Medicine's Dr. Steven L. Zeichner ...
Jan 28, 2026
0
0
mRNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are produced through specialized immune structures called germinal centers, but until now it was not fully ...
Dec 17, 2025
0
0
In the 1966 film Fantastic Voyage, a spacecraft and its crew are shrunk to microscopic size and injected into the body of an injured astronaut to remove a life-threatening blood clot from his brain. The Academy Award-winning ...
Dec 2, 2025
0
0
The Food and Drug Administration's COVID-19 vaccine approval issued Aug. 27 comes with restrictions on who's eligible to receive the vaccine. Meanwhile, the administration has endorsed seasonal influenza vaccines—but only ...
Aug 29, 2025
0
0
Belgian scientists have uncovered new details about how the immune system responds to vaccines. Dendritic cells, which are key immune messengers that help kick-start the body's defenses, show specific responses to lipid nanoparticles. ...
Aug 26, 2025
0
1
For 30 years, vaccine recommendations from the Centers for Disease Control and Prevention have aligned closely with those from the American Academy of Pediatrics, or AAP. But on Aug. 19, 2025, the AAP published new vaccine ...
Aug 21, 2025
0
1
US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna over the COVID-19 vaccine.
Aug 1, 2025
0
0
Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children with medical conditions that put them at higher risk of severe illness.
Jul 11, 2025
0
0
Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the rare but serious condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT).
Jul 8, 2025
0
0
Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialized in mRNA technology with the goal of advancing cancer treatments.
Jun 12, 2025
0
0
